U.S. opts for 100M more doses of Pfizer-BioNTech COVID-19 vaccine

By The Science Advisory Board staff writers

The U.S. government has exercised its option for an additional 100 million doses of the Pfizer-BioNTech COVID-19 vaccine

The U.S. government's order brings the total number of doses committed from Pfizer and BioNTech to 300 million or enough to vaccinate 150 million people under the two-dose regimen.

According to the agreement, the U.S. government will pay $1.95 billion for the additional 100 million doses. These doses will be provided for free to eligible U.S. residents as part of the government's commitment for free access to COVID-19 vaccines.

The vaccine doses will continue to be manufactured at Pfizer's Kalamazoo, MI, manufacturing site, according to the firms.


Copyright © 2021 scienceboard.net
 

To read this and get access to all of the exclusive content on The Science Advisory Board create a free account or sign-in now.

Member Sign In:
MemberID or email address:  
Do you have a Scienceboard.net password?
No, I want a free membership.
Yes, I have a password:  
Forgot your password?
Sign in using your social networking account:
Sign in using your social networking
account: